Downstream Only - Processing for microbial derived proteins
Product Description
Boehringer Ingelheim Biopharmaceuticals GmbH
-
DE -
2023On CPHI since
-
5000+Employees
Company types
Boehringer Ingelheim Biopharmaceuticals GmbH
-
DE
-
2023On CPHI since
-
5000+Employees
Company types
More Products from Boehringer Ingelheim Biopharmaceuticals GmbH (5)
-
.jpg)
Product Drug Substance Manufacturing - Mammalian Cell Cultures
• Around 430,000 L total commercial capacity for cell culture • Manufacturing sites around the globe: Biberach/Germany, Vienna/Austria, Fremont, CA/USA and Shanghai/ China- from 2,000 up to 15,000 L bioreactors • GMP facilities licensed by EMA, FDA, MHLW and other authorities ... -
Product Drug Substance Manufacturing - Microbial Fermentation
12,000 L commercial manufacturing capacity in multi-licensed facility Two trains each with 6,000 L of capacity which can be used with flexible scales
Large-scale GMP facilities licensed by EMA, FDA & MHLW for clinical and commercial global supplies
Protein refol... -
Product Aseptic Filling
• Clinical and commercial capacities and technology for vials • Formulations for liquids and lyophilizates vials (flexible vial sizes from 2 mL to 100 mL) • Flexible filling volumes for clinical and commercial supply • Manual and automated visual inspections • Globally licensed ... -
Product Early development service for microbial fermentation
High throughput process development services for E. coli and yeast based on high degree of automation and digitalization to speed up time to clinic for diverse protein formats e.g., scaffolds, enzymes, pDNA, sub-unit vaccines and antibody fragments. Service description: - Genetic engineering, cell line an... -
Product Tech Transfer
Efficient tech transfers from customers or within own global bio-manufacturing network, launch preparation and commercial supply readiness for drug substance and drug product. Service description: - Long-standing track record in product launches - 47 biopharmaceuticals brought to the market - Tailored to...
Boehringer Ingelheim Biopharmaceuticals GmbH resources (4)
-
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
Whitepaper Advancements in microbial manufacturing of biopharmaceuticals
Advancements in Microbial Manufacturing of Biopharmaceuticals: A Historical Perspective and Future Outlook. -
Video New Cell Culture Facility in Vienna
We are is raising the bar with the LSCC (Large Scale Cell Culture), the new biopharmaceutical multi-product facility, in Vienna. It is one of the most modern buildings of its kind with a high degree of automation and flexibility.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance